EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy
Links shared publicly online about this topic.
- 402total visits
EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Commission has granted marketing authorisation for Trobalt as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.
View full resource at news-medical.net
Tags: Seizure, Epilepsy, Pharma, GlaxoSmithKline
Most Recently Shared on March 30, 2011 at 7:23 am By:
Epilepsy News: EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy: GlaxoSmithKline a... http://bit.ly/eYc0T1
Also Shared By:
Advertisement
News-Medical.Net
@NewsMedical
EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy: GlaxoSmithKline and Valeant Phar... http://bit.ly/eYc0T1
1 year ago...